TITLE

String test of hypervirulent Klebsiella pneumonia

AUTHOR(S)
Kumabe, A.; Kenzaka, T.
PUB. DATE
December 2014
SOURCE
QJM: An International Journal of Medicine;Dec2014, Vol. 107 Issue 12, p1053
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
99750839

 

Related Articles

  • Concomitant arginine-vasopressin and hydrocortisone therapy in severe septic shock: association with mortality. Torgersen, Christian; Luckner, Günter; Schröder, Daniel C. H.; Schmittinger, Christian A.; Rex, Christopher; Ulmer, Hanno; Dünser, Martin W. // Intensive Care Medicine;Sep2011, Vol. 37 Issue 9, p1432 

    Purpose: To evaluate the association between concomitant arginine-vasopressin (AVP)/hydrocortisone therapy and mortality in severe septic shock patients. Methods: This retrospective study included severe septic shock patients treated with supplementary AVP. To test the association between...

  • Antibiotic trends of Klebsiella pneumoniae and Acinetobacter baumannii resistance indicators in an intensive care unit of Southern Italy, 2008-2013. Agodi, Antonella; Barchitta, Martina; Quattrocchi, Annalisa; Maugeri, Andrea; Aldisio, Eugenia; Marchese, Anna Elisa; Mattaliano, Anna Rita; Tsakris, Athanassios // Antimicrobial Resistance & Infection Control;11/3/2015, Vol. 4, p1 

    Background: The overuse of antimicrobials is one of the main factors responsible for the development and spread of antimicrobial resistance, together with other causes, such as intra- and inter-hospital spread of resistant microorganisms and infection control policies and practices. The...

  • Extended drotrecogin alfa (activated) treatment in patients with prolonged septic shock. Dhainaut, Jean-Francois; Antonelli, Massimo; Wright, Patrick; Desachy, Arnaud; Reignier, Jean; Lavoue, Sylvain; Charpentier, Julien; Belger, Mark; Cobas-Meyer, Michael; Maier, Cornelia; Mignini, Mariano A.; Janes, Jonathan // Intensive Care Medicine;Jul2009, Vol. 35 Issue 7, p1187 

    To determine the efficacy and safety of extended drotrecogin alfa (activated) (DAA) therapy. Multicentre, randomised, double-blind, placebo-controlled study. Sixty-four intensive care units in nine countries. Adults with severe sepsis and vasopressor-dependent hypotension after a 96-h infusion...

  • Tratamiento quirúrgico de las complicaciones del shock meningocóccico grave. Roca, P. Casteleiro; Miguez, J. Midón; Barreiro, J. García; Martelo Villar, F. // Cirugía Plástica Ibero-Latinoamericana;2010, Vol. 36 Issue 2, p155 

    Meningococcal shock is a relatively frequent disease with a serious prognosis, that causes a multiorganic failure with high mortality and Intensive Care Unit admission. Serious meningococcal shock causes tissue necrosis by uncertain physiopathology. In the last years, there is an increase of the...

  • Observancia de las guías internacionales de manejo temprano en sepsis grave y choque séptico. Quintero, Ricardo Andrés; Martínez, Carlos Arturo; Gamba, Juan Diego; Ortiz, Isadora; Jaimes, Fabián // Biomédica: Revista del Instituto Nacional de Salud;Sep2012, Vol. 32 Issue 3, p449 

    Introduction. Complete adherence to early goal-directed therapy has shown a significant reduction in 28-day mortality rate, whereas partial adherence has not shown beneficial effect. Objectives. The effect of adherence to 6 hour sepsis bundle treatment was evaluated on patients with severe...

  • Sepsis Yönetiminde Ne DeÄŸiÅŸti? Elay, Gülseren; Gündoğan, Kürşat; Coşkun, Ramazan // Turkish Journal of Medical & Surgical Intensive Care Medicine / ;Apr2014, Vol. 5 Issue 1, p11 

    The most important reasons of mortality and morbidity in the intensive care unit are severe sepsis and septic shock. It is estimated that more than 200,000 patients in the USA and more than 150,000 patients in Europe die with a diagnosis of severe sepsis every year. In sepsis, an excessive and...

  • Early Use of Polymyxin B Hemoperfusion in Abdominal Septic Shock. Cruz, Dinna N.; Antonelli, Massimo; Fumagalli, Roberto; Foltran, Francesca; Brienza, Nicola; Donati, Abele; Malcangi, Vincenzo; Petrini, Flavia; Volta, Giada; Bobbio Pallavicini, Franco M.; Rottoli, Federica; Giunta, Francesco; Ronco, Claudio // JAMA: Journal of the American Medical Association;6/17/2009, Vol. 301 Issue 23, p2445 

    The article discusses a preliminary study which investigated the early use of polymyxin B hemoperfusion in abdominal septic shock. A prospective, multicenter, randomized controlled trial was conducted at 10 Italian tertiary care intensive care units between December 2004 and December 2007, which...

  • Venous-to-arterial carbon dioxide difference: an experimental model or a bedside clinical tool? Møller, Morten; Cecconi, Maurizio; Møller, Morten Hylander // Intensive Care Medicine;Feb2016, Vol. 42 Issue 2, p287 

    The authors discuss a study on the relation between venous-to-arterial carbon dioxide difference (Pv-aCO2) and microvascular perfusion in patients with early septic shock, by G.A. Ospina-Tascon and colleagues, which has been published in journal. They note that septic shock condition is a...

  • Caracterización Molecular y Detección de Betalactamasas de Espectro Extendido en Cepas de E. coli y K. pneumoniae Aisladas en las Unidades de Cuidados Intensivos de un Hospital Universitario. Perozo-Mena, Armindo; Castellano-González, Maribel; Ginestre-Pérez, Messaria; Harris, Belinda // Revista Kasmera;jul-dic2007, Vol. 35 Issue 2, p91 

    Extended Spectrum Betalactamases production from E. coli and K. pneumoniae strains, is a serious public health problem since cause loss of therapeutic effectiveness of betalactams antibiotics. In this research the presence of extended spectrum betalactamases was investigated in E. coli and K....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics